AUTOLUS THERAPEUTICS PLC (AUTL)
Autolus Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Business Updates
Autolus Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Business Updates
Tozorakimab met primary endpoint in both OBERON and TITANIA Phase III trials in patients with COPD
Werewolf Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Updates
OTC Markets Group Welcomes Orvana Minerals Corp. to OTCQX
Satellos Reports 2025 Financial Results and Highlights Recent Company Progress
Re: Notice of Meeting and Definitive Proxy Statement for 2026 Annual General Meeting
Re: Notice of Meeting and Definitive Proxy Statement for 2026 Annual General Meeting
SBCメディカルグループ、2025年第4四半期及び通期決算発表(参考和訳版)
SBC Medical Announces Fourth Quarter and Full Year 2025 Financial Results
Trilogy Metals Announces Date of Annual Shareholders Meeting